[Mechanism of electroacupuncture at "Yingxiang-Hegu" (LI20-LI4) acupoints ameliorating allergic rhinitis in rats via modulating ILC2s through the IL-33/ST2 pathway].
Wu Han H, Lü Heng H, Zhang Hao H, Hu Zhixiang Z et al.
To investigate the regulatory effects of electroacupuncture at "Yingxiang-Hegu" (LI20-LI4) acupoints on the interleukin (IL)-33/growth stimulation expressed gene 2 (ST2) signaling pathway and type 2 innate lymphoid cells (ILC2s) in the nasal mucosa of allergic rhinitis (AR) rats, and to explore its therapeutic mechanism for AR. Forty-eight SD rats were randomly divided into a control group (n=12) and a modeling group (n=36). Ovalbumin (OVA)-induced AR model was established. Thirty-six successfully modeled rats were further randomized into a model group (n=12), a western medicine group (n=12), and an electroacupuncture group (n=12). The electroacupuncture group received acupuncture at the paired points "Yingxiang-Hegu"(LI20-LI4) with the ipsilateral LI20 and LI4 points connected to an electroacupuncture device. Stimulation parameters were set as follows:sparse-dense wave, frequency 2 Hz /100 Hz, current intensity 1-2 mA, needle retention for 20 min. The western medicine group received oral administration of loratadine(0.1 mg/100 g). Interventions were administered once daily for 14 consecutive days in all groups. Nasal allergy symptoms (nose scratching, sneezing and nasal discharge) were observed and scored before and after modeling, as well as after intervention. After intervention, histopathological change in the nasal mucosal tissue was examined via hematoxylin and eosin (HE) staining. ELISA was used to detect serum ovalbumin-specific immunoglobulin E (OVA-sIgE), IL-9, and IL-13 levels. Immunofluorescence double staining was used to assess ST2 and thymic cell antigen 1 (Thy1, also known as CD90) positive expression and ILC2s numbers in nasal mucosal tissue. Real-time quantitative PCR was used to detect the mRNA expression levels of GATA binding protein 3(GATA3), retinoic acid-related orphan receptor alpha (ROR-α), IL-33, ST2, IL-1 receptor accessory protein (IL-1RAcP), myeloid differentiation primary-response protein 88 (MyD88), i IL-1 receptor-associated kinase 4 (IRAK4), and nuclear factor κB p65 subunit (NF-κB p65) in nasal mucosal tissue. Western blot was used to measure the protein expression levels of IL-33, ST2 and MyD88 in nasal mucosal tissue. Following OVA sensitization, nasal allergy symptom scores in the model group were significantly elevated compared to the control group (all>5 points, P<0.001), indicating successful modeling. After intervention, the nasal allergy symptom scores in the model group remained persistently high compared to the control group (P<0.001). HE staining revealed disrupted nasal mucosal barrier and marked inflammatory response. Serum OVA-sIgE, IL-9 and IL-13 levels were significantly elevated (P<0.001);the number of ILC2s in the nasal mucosa significantly increased (P<0.001), with enhanced fluorescence intensities of ST2 and Thy1 (P<0.001). GATA3, ROR-α, IL-33, ST2, IL-1RAcP, MyD88, IRAK4 and NF-κB p65 mRNA expression levels were elevated (P<0.001, P<0.01), while IL-33, ST2 and MyD88 protein expression levels were increased (P<0.001). Compared with the model group, both the electroacupuncture and western medicine groups showed a reversal of all the above indicators (P<0.001, P<0.01, P<0.05);HE staining revealed reduced inflammatory infiltration in the nasal mucosa and improved tissue structural integrity. No statistically significant differences were observed between the electroacupuncture group and the western medicine group for any of the measured indicators. Electroacupuncture at "Yingxiang-Hegu"(LI20-LI4) acupoints ameliorates OVA-induced nasal mucosal inflammatory changes in AR rats. This effect may be mediated by inhibiting the IL-33/ST2 signaling pathway and down-regulating ILC2s expression, thereby improving allergic rhinitis in rats.